vTv Therapeutics (VTVT) Shares Issued (2018 - 2025)

vTv Therapeutics has disclosed Shares Issued across 6 years of filings, most recently posting $7000.0 for Q4 2025.

• Shares Issued for Q4 2025 came in at $7000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $7000.0 (changed N/A YoY), and the FY2025 annual result was $16000.0, changed N/A from the prior year.
• Shares Issued came in at $7000.0 for Q4 2025 at vTv Therapeutics, up from -$5.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $17.0 million in Q3 2021 to a low of -$5.0 million in Q4 2022.
• The 3-year median for Shares Issued is $5.3 million (2021), against an average of $5.1 million.
• Peak annual rise in Shares Issued reached 580.0% in 2021, while the deepest fall reached 27.4% in 2021.
• vTv Therapeutics' Shares Issued stood at $17.0 million in 2021, then plunged by 129.65% to -$5.0 million in 2022, then soared by 100.14% to $7000.0 in 2025.
• The last three Shares Issued figures came in at $7000.0 (Q4 2025), -$5.0 million (Q4 2022), and $17.0 million (Q3 2021), per Business Quant data.